HER2-Positive Metaplastic Breast Cancer with Resistance to Neoadjuvant Chemotherapy: Case Report

INTRODUCTION: Metaplastic breast carcinoma (MBC) is a rare histologic subtype of breast carcinoma, which is usually negative for estrogen receptor, progesterone receptor, and HER2. HER2-positive MBC is therefore extremely rare. Most MBCs have poor response to chemotherapy. HER2-targeted neoadjuvant...

Descripción completa

Detalles Bibliográficos
Autores principales: Tateishi, Kaho, Kiyoi, Megumi, Miyasaka, Miwako, Kawaji, Mari, Nakanishi, Hitomi, Furuta, Yuki, Nishimatsu, Mana, Takahashi, Yuichi, Nishikawa, Mizuki, Nishimura, Yoshiharu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10673346/
https://www.ncbi.nlm.nih.gov/pubmed/38028581
http://dx.doi.org/10.1159/000534847

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10673346/
https://www.ncbi.nlm.nih.gov/pubmed/38028581
http://dx.doi.org/10.1159/000534847

Ejemplares similares